Your browser doesn't support javascript.
loading
Alcohol consumption, blood DNA methylation and breast cancer: a Mendelian randomisation study.
Zhou, Xuan; Yu, Lili; Wang, Lijuan; Xiao, Jiarui; Sun, Jing; Zhou, Yajing; Xu, Xiaolin; Xu, Wanghong; Spiliopoulou, Athina; Timofeeva, Maria; Zhang, Xiaomeng; He, Yazhou; Yang, Haomin; Campbell, Harry; Zhang, Ben; Zhu, Yimin; Theodoratou, Evropi; Li, Xue.
Afiliação
  • Zhou X; Department of Big Data in Health Science School of Public Health, and Centre of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Yu L; The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Hangzhou, China.
  • Wang L; Department of Big Data in Health Science School of Public Health, and Centre of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Xiao J; The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Hangzhou, China.
  • Sun J; Department of Big Data in Health Science School of Public Health, and Centre of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Zhou Y; The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Hangzhou, China.
  • Xu X; Department of Big Data in Health Science School of Public Health, and Centre of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Xu W; The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Hangzhou, China.
  • Spiliopoulou A; Department of Big Data in Health Science School of Public Health, and Centre of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Timofeeva M; The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Hangzhou, China.
  • Zhang X; Department of Big Data in Health Science School of Public Health, and Centre of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • He Y; The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Hangzhou, China.
  • Yang H; Department of Big Data in Health Science School of Public Health, and Centre of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Campbell H; The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Hangzhou, China.
  • Zhang B; School of Public Health, Fudan University, Shanghai, China.
  • Zhu Y; Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Theodoratou E; Danish Institute for Advanced Study (DIAS), Epidemiology, Biostatistics and Biodemography Research Unit, Institute of Public Health, University of Southern Denmark, Odense, Denmark.
  • Li X; Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK.
Eur J Epidemiol ; 37(7): 701-712, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35708873

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article